NEUROLOGISK KLINIK ApS: Financial statements 2022
CVR: 31748429
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. That is a decrease of 61.4% compared with the year before. Equity in the 2022 report amounted to DKK 1,716,091. The solvency ratio was 74.9%.
- Gross Profit
- DKK 99,955
- Profit/Loss
- DKK 265,911
- Equity
- DKK 1,716,091
- Total Assets
- DKK 2,290,477
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 100K | 266K | 1.7M | 0 |
| 2021 | - | 259K | 700K | 1.5M | - |
| 2020 | - | 161K | 195K | 863K | - |
| 2019 | - | 259K | 145K | 521K | - |
| 2018 | - | 89K | 13K | 376K | 0 |
Official annual report
Keep an eye on NEUROLOGISK KLINIK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NEUROLOGISK KLINIK ApS has published its annual report for 2021. Gross profit came to DKK 258,821, and the net result was DKK 699,794.
About NEUROLOGISK KLINIK ApS
NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.